{
    "organizations": [],
    "uuid": "2fe16b4b1be04e7ed828cdef22d7646b75cab41b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-valeant-to-reduce-debt-by-an-addit/brief-valeant-to-reduce-debt-by-an-additional-200-million-idUSASB0C2FI",
    "ord_in_thread": 0,
    "title": "BRIEF-Valeant To Reduce Debt By An Additional $200 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - Valeant Pharmaceuticals International Inc :\n* VALEANT WILL REDUCE DEBT BY AN ADDITIONAL $200 MILLION * VALEANT - ‍PUT IN NOTICE TO PAY DOWN AN ADDITIONAL $200 MILLION OF ITS SENIOR SECURED TERM LOANS, USING CASH ON HAND​\n* VALEANT - WHEN DEBT IS REPAID NEXT WEEK, CO TO HAVE REDUCED DEBT, IN AGGREGATE, BY MORE THAN $6.7 BILLION SINCE END OF Q1 OF 2016\n* VALEANT - CO‘S TOTAL LONG-TERM DEBT TO BE ABOUT $25.5 BILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-25T22:04:00.000+02:00",
    "crawled": "2018-01-25T22:17:13.019+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "valeant",
        "pharmaceutical",
        "international",
        "inc",
        "valeant",
        "reduce",
        "debt",
        "additional",
        "million",
        "valeant",
        "notice",
        "pay",
        "additional",
        "million",
        "senior",
        "secured",
        "term",
        "loan",
        "using",
        "cash",
        "valeant",
        "debt",
        "repaid",
        "next",
        "week",
        "co",
        "reduced",
        "debt",
        "aggregate",
        "billion",
        "since",
        "end",
        "q1",
        "valeant",
        "co",
        "total",
        "debt",
        "billion",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}